Microalgae-Based Aquafeed Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Microalgae-Based Aquafeed Market Trends and Insights

Rapid Cost Decline in Closed-Photobioreactor Farming

Closed photobioreactors are cutting operating expenses below USD 3 per kilogram of dry biomass, closing the historical gap with fishmeal and spurring wider use of algae in premium salmon and shrimp feeds. Algiecel secured DKK 50 million (USD 6.7 million) in 2024 to deploy modular units at industrial emission points, demonstrating the scalability of mobile systems that capture waste carbon dioxide at source. Lifecycle analyses indicate Spirulina production costs could fall to USD 1.30 per kilogram at full scale, positioning algae near price parity with fishmeal as long as spot prices stay above USD 1,700 per metric ton. The closed-system design also eliminates contamination from mycotoxins and heavy metals, a key requirement for premium formulations in the microalgae-based aquafeed market. Regulators such as the United States Food and Drug Administration and the European Food Safety Authority favor photobioreactor-grown strains for their traceability, shortening approval times versus open-pond alternatives.

Premium Pricing Opportunity for Antibiotic-Free Seafood

Retailers in Europe and North America pay double-digit premiums for antibiotic-free salmon and shrimp, giving farmers a direct economic incentive to adopt immune-boosting algal ingredients. The Veramaris Big Data Chile study 2026 study covering 143 million Chilean salmon showed diets containing at least 7.2% combined eicosapentaenoic acid and docosahexaenoic acid improved feed conversion ratios and cut quality downgrades by up to 100%, reinforcing the cost–benefit case for algae inclusion. Trials with Microchloropsis gaditana increased fillet omega-3 content by 23% and reduced bacterial infections by 85.68%, demonstrably lowering antibiotic use. Similar effects were observed in shrimp, where Spirulina at 10% inclusion increased final weight to 10.82 grams and halved Vibrio mortality, demonstrating that microalgae-based aquafeed market solutions can drive both health and financial gains. As consumer awareness continues to rise, antibiotic-free labeling is moving from a differentiator to a prerequisite in premium channels, cementing algae’s role in high-value aquaculture.

Corporate Net-Zero Pledges are Accelerating Algae Inclusion

Feed buyers face mounting scrutiny over Scope 3 emissions, encouraging the switch from fishmeal to microalgae that cuts 1.5-2.0 metric tons of carbon dioxide equivalents per metric ton replaced. BioMar Group purchased the LetSea research center in 2025 to develop net-zero diets and aims to phase out marine ingredients in European seabass and gilthead seabream feeds by 2028. Industrial carbon-capture projects in Norway sequester 300,000 metric tons of carbon dioxide annually to cultivate algae for salmon feed, and associated carbon-credit revenue offsets 10-15% of biomass production costs. Lenders and investors are beginning to price carbon exposure into capital costs, so adopters of algae-rich feeds gain preferential financing, reinforcing demand within the microalgae-based aquafeed market.

Regenerative Aquaculture Certifications are Emerging

New labels that require nutrient circularity and ecosystem restoration, such as Seaforest, demand verifiable algae inputs to demonstrate closed-loop nutrient management. The European Union-funded ALLIANCE project (2025-2029) is building integrated microalgae biorefineries that treat aquaculture wastewater while producing feed-grade biomass, directly linking compliance with effluent limits to algae adoption. King Abdullah University of Science and Technology operates a 42,000-square-meter facility cultivating seawater-adapted Spirulina and Chlorella, capturing 1.8 kilograms of carbon dioxide per kilogram of biomass, and illustrating the regenerative model’s scalability^{[1]Source: King Abdullah University of Science and Technology, “KAUST Biotechnology Solution Could Be Key to Unlocking Saudi Food Security,” KAUST, kaust.edu.sa}. Early adopters in Australia and New Zealand leverage regenerative certification to access premium markets in Japan and South Korea, where consumers reward restorative farming. Because no single global standard exists, producers investing now in traceability systems and lifecycle data build first-mover credibility in the evolving microalgae-based aquafeed market.

Regulatory Approval Lag for Novel Algae Strains

The United States Food and Drug Administration's Generally Recognized as Safe pathway and the European Union's Novel Food regulation can add 2-3 years and significant documentation costs before the commercial launch of new strains^{[2]Source: European Food Safety Authority, “Homepage,” European Food Safety Authority, efsa.europa.eu} . This delay is acute for CRISPR-edited high-EPA algae that offer superior lipid profiles yet face stricter scrutiny, especially in Europe and Japan, where public skepticism toward gene editing persists. Companies such as KnipBio secured United States and Canadian approvals for bacterial biomass in 2025 but still await European clearance, limiting scale-up across the microalgae-based aquafeed market. Regulatory fragmentation forces producers to maintain separate production lines, duplicating costs and slowing global rollouts. Lack of harmonization under Codex Alimentarius keeps the approval lag a structural restraint in the medium term.

Public Perception of Genetically Edited Algal Feeds

European Commission’s consumer surveys in 2024 showed that 42% of Europeans would avoid seafood fed with gene-edited ingredients, signaling a reputational risk for farmers using CRISPR-modified algae^{[3]Source: European Commission, “Homepage,” European Commission, ec.europa.eu} . Japan enforces labeling requirements for gene-edited feed components, complicating supply chains and potentially stigmatizing end products. In contrast, the United States market is more accepting, but global brands must harmonize labeling and cannot ignore perception hotspots. Large producers such as Veramaris deliberately avoid gene editing to sidestep controversy, but that strategy caps performance potential relative to engineered strains. Unless transparent communication campaigns shift public opinion, consumer resistance will remain an overhang on the microalgae-based aquafeed market, especially in premium retail channels.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Product Type: Protein Isolates Emerging as Fastest Segment

Algal oil held the largest 38.0% share of the microalgae-based aquafeed market in 2025, as salmon producers rely on its stable docosahexaenoic acid profile to secure premium fillet pricing. In contrast, protein isolates are the fastest segment and are projected to grow at a 13.5% CAGR during 2026-2031 as shrimp hatcheries in Thailand, Ecuador, and India replace fishmeal with high-protein concentrates that lift larval survival. The microalgae-based aquafeed market size for isolates is expanding further as the United States Food and Drug Administration's Generally Recognized as Safe rules and the European Union's Novel Food reviews favor standardized compositions that streamline safety checks. Cost declines in closed photobioreactors and the ability to monetize carbon credits narrow the price gap with fishmeal, reinforcing the adoption of the fastest segment.

Whole microalgae and algal meal occupy niche positions that deliver pigmentation and immune benefits to tilapia and ornamental fish at 5-15% inclusion, even when cell wall barriers reduce digestibility. Algal oil is still forecast to grow at a solid CAGR through 2031 as multi-year supply contracts ensure steady demand in premium salmon and marine finfish feeds. Multi-functional oils, such as the Omega Origins launched by Fermentalg in 2026, contain 40% eicosapentaenoic acid and 20% docosahexaenoic acid. These oils reduce post-processing steps and lower finished-feed costs. Producers that can co-cultivate multiple strains inside modular systems gain flexibility to supply blended ingredients that meet diverse nutrient targets across the remaining segments.

By Species: Schizochytrium Retains Largest Share While Nannochloropsis Is Fastest Rising

Schizochytrium delivered the largest 32.0% microalgae-based aquafeed market share in 2025 because its high docosahexaenoic acid content and fermentation consistency meet premium salmon specifications. Nannochloropsis is the fastest-growing species segment and is projected to expand at a 14.0% CAGR over 2026-2031, following rainbow trout trials that confirmed full fishmeal replacement with equal growth and up to 40% lower phosphorus discharge. Declining photobioreactor costs and the environmental bonus of displacing as much as 2 metric tons of carbon dioxide equivalents per metric ton of fishmeal reinforce demand for Nannochloropsis. Feed formulators increasingly combine the largest and fastest strains to balance docosahexaenoic acid and eicosapentaenoic acid in a single pellet, streamlining logistics in a tightening sustainability landscape.

Spirulina is experiencing steady growth, valued for its pigmentation properties and immune support benefits in shrimp and tilapia, even when inclusion levels reach their maximum without pre-treatment. Chlorella remains niche because high fiber content lowers digestibility for carnivorous fish, unless costly cell-wall disruption is added, limiting its current market size. Competitive pressure is rising from bacterial single-cell proteins, so algae producers now market multi-strain blends that pair Spirulina for color with Schizochytrium for docosahexaenoic acid and Nannochloropsis for eicosapentaenoic acid in one feed solution.

Geography Analysis

Europe delivered the largest 35.5% share of the microalgae-based aquafeed market in 2025, as Norwegian and Danish salmon farmers adopted algal oils to meet Marine Stewardship Council traceability and antibiotic-free standards. Asia-Pacific is the fastest region, forecast to expand at a 10.7% CAGR from 2026-2031 on the back of India’s zero-tariff algal oil policy and China’s alternative-protein incentives. Europe continues to channel public funding into microalgae biorefineries that clean aquaculture effluent, while Asia-Pacific leverages import duty cuts to narrow the cost gap with fishmeal. These contrasting yet complementary policy drivers underpin divergent growth paths in the largest and fastest regional markets.

North America is growing steadily as Food and Drug Administration approvals open the door for novel strains and as salmon producers integrate algae to curb Scope 3 emissions. South America benefits from Chilean data showing improved feed conversion ratios and fewer downgrades when algal oils exceed 7.2% combined long-chain omega-3 content. The Middle East scales seawater-adapted Spirulina and Chlorella facilities that link carbon capture with inland aquaculture expansion. Africa remains early-stage, with pilot projects in Egypt and South Africa awaiting further cost declines before commercial rollouts.

Regional investment patterns signal accelerating capacity additions. European photobioreactor hubs in Scotland and France target multi-fold capacity jumps by 2027, while Japanese and South Korean pilots validate technology ahead of full commercialization. New carbon-credit programs in Norway and California offset up to 15% of production cost, making algae more competitive and fuelling cross-continental interest. As fishmeal volatility persists and sustainability labels harden, every major aquaculture zone is projected to widen algae usage, collectively expanding the global microalgae-based aquafeed market.